<H2> EVENT UPDATES </H2> |
<H2> TRENDING AT OIS </H2> |
<H2> The OIS All Stars of Ophthalmic Innovation </H2> |
<H2> TESTIMONIALS </H2> |
<H2> SUBSCRIBE TO OUR NEWSLETTER </H2> |
<H3> OIS </H3> |
<H3> LEARN MORE </H3> |
<H3> LEARN MORE </H3> |
<H3> LEARN MORE </H3> |
<H3> LEARN MORE </H3> |
<H3>
Discover the latest trending news, podcasts, videos from OIS covering corporate leaders and innovators.
</H3> |
<H3> A STORY TO TELL? </H3> |
<H3>
Why People Attend OIS
</H3> |
<H3> TOM MITRO </H3> |
<H3> YARI MITCHELL </H3> |
<H3> JAG DOSANJH </H3> |
<H4> Get Involved </H4> |
<H4> Connect With Us </H4> |
<H5> Do You Have </H5> |
<H6>
Powerhouse Investor Panel Shares Lessons for Building Out Your 2021 Portfolio
</H6> |
<H6>
Venturing into Ophthalmology with ExSight
</H6> |
<H6>
The Outlook on Getting Regulatory-Approved Bevacizumab to Market
</H6> |
<H6>
A Vision for Building a Business with Jerry St. Peter of Eyevance
</H6> |
<H6>
Retina Industry Leaders Impart Pearls of Wisdom for Finding Your Place in the Retina Space
</H6> |
<H6>
The Strategy Behind EyeGate’s Acquisition of Panoptes
</H6> |
<H6>
Lessons learned for Conducting Clinical Trials in Challenging Times
</H6> |
<H6>
Looking Ahead to 2021, Finding Value in 2020’s Lessons
</H6> |
<H6>
Novartis Steps Up Digital Strategy for AMD Treatments and Patient Support
</H6> |
<H6>
800-pound Gorilla Doesn’t Deter Investors in Ophthalmology Sector
</H6> |
<H6>
Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs
</H6> |
<H6>
Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary
</H6> |
<H6>
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol
</H6> |
<H6>
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering
</H6> |
<H6>
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery
</H6> |
<H6>
OIS Index Rallies Back from COVID-Driven Decline
</H6> |
<H6>
OIS Index Posts a Strong Finish to 2019
</H6> |
<H6>
OIS Index Outperforms
</H6> |
<H6>
OIS Index on Positive Upswing
</H6> |
<H6>
OIS Index Deep in Bear Territory in Q3
</H6> |
ISP